Dingyuan Y. Hu
Wenzhou, 325000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
CLCA1 Modulates Pancreatic Cancer Proliferation via SIRT1-HIF-1α Pathway.
Journal: Clinical laboratory
Published: June 15, 2026
Analysis of influencing factors on the efficacy of vedolizumab in the treatment of ulcerative colitis patients
Journal: Zhonghua yi xue za zhi
Published: August 05, 2025
Matrix remodeling-associated protein 5 as a novel biomarker for predicting disease activity and endoscopic response to infliximab in Crohn's disease.
Journal: Journal of translational autoimmunity
Published: May 16, 2025
Clinical efficacy and its influencing factors of ustekinumab in the treatment of patients with Crohn's disease
Journal: Zhonghua yi xue za zhi
Published: November 05, 2024
Global, regional, and national burden of inflammatory bowel disease, 1990-2021: Insights from the global burden of disease 2021.
Journal: International journal of colorectal disease
Published: August 28, 2024
Analysis on the efficacy of dual vein induction therapy of Ustekinumab in complex perianal fistulizing Crohn's disease
Journal: Zhonghua yi xue za zhi
Published: November 05, 2023
Efficacy, tolerability, and safety of 1.5L-lactulose as bowel preparation for patients with inflammatory bowel disease: a randomized, single-blinded trial.
Journal: Internal and emergency medicine
Published: November 01, 2023
The associations of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene polymorphisms with the risk of Crohn's disease in Chinese patients
Journal: Zhonghua yi xue za zhi
Published: August 25, 2022
The association of parameters of body composition and laboratory markers with the severity of hypertriglyceridemia-induced pancreatitis.
Journal: Lipids in health and disease
Published: December 18, 2020
Association of Breg cells and Treg cells with the clinical effects of Infliximab in the treatment of Chinese patients with Crohn's disease
Journal: Zhonghua yi xue za zhi
Published: November 17, 2020
Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic marker.
Journal: Journal of translational medicine
Published: April 18, 2020
Last Updated: 09/26/2026